Search
for
Sort by
Research 91–120 of 1000+
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Vitamin D-dependent Rickets Type II
- DRUG‐ASSOCIATED ALOPECIA
- Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors
- Current and future pharmacotherapy for alopecia areata
- To evaluate the causes and possible treatments for alopecia seborrheic in adolescents
- Alopecias
- Alopecia Areata
- Comparison of Components of Metabolic Syndrome in Androgenic Alopecia versus Healthy Population
- Re: Associations Between Variants in the Cyclooxygenase 2 Enzyme Gene (PTGS2) and Development of Benign Prostate Enlargement
- Histopathology of non-scarring alopecia
- Postoperative Alopecia Following Orthognathic Surgery
- Synthesis of Spiro[cyclohexane-1,2?-[2H]indene] derivatives as inhibitors of steroid 5?-reductase
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Autoimmune polyglandular syndrome type 4 – case report
- METHOTREXATE FOR GENERALIZED PUSTULAR PSORIASIS IN A 2-YEAR-OLD CHILD
- Efficacy of type A botulinum toxin treatment for androgenetic alopecia using ultrasound combined with trichoscopy
- Response to Corona-Rodarte et al.’s “Pressure alopecias: a review”
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Diabetes, ovarian tumor, hyperparathyroidism, and papillary cancer: A chance association?
- Radiation-induced Alopecia Treated with Botulinum Toxin Type A Injection
- Bibbidi bobbidi bald: Two “hairowing” tales of Princess Package hairstyles
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Metabolic risk in PCOS: phenotype and adiposity impact
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Obesity and the skin
- How to diagnose a lipodystrophy syndrome